Remdesivir Compulsory Licensing Issuance Rejected by Russia
Russia’s Supreme Court rejected US Company Gilead Sciences lawsuit challenging the Russian government’s decision for development and marketing anti-covid-19 drug Remdesivir with the consent of Gilead. Read more: https://bit.ly/3wdduvk